Reuters - Merck & Co said on Monday that patients on its experimental obesity drug lost more than twice as much weight as those on a placebo in a late-stage clinical study.

This entry was posted on Monday, March 31st, 2008 at 4:36 pm and is filed under Weight Loss News.